Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia.

Authors :: Arslan S
Zhang J
Dhakal P
Moran J
Naidoo N
Lombardi J
Pullarkat V
Stein AS
Marcucci G
Yaghmour G
Bhatt VR
Fathi AT
Aldoss I
Source :: American journal of hematology [Am J Hematol] 2021 Mar 01; Vol. 96 (3), pp. E59-E63. Date of Electronic Publication: 2020 Dec 08.
Publication Year :: 2021

Subjects :: Adult
Aged
Aged, 80 and over
Bridged Bicyclo Compounds, Heterocyclic administration & dosage
DNA Methylation drug effects
Decitabine administration & dosage
Drug Evaluation
Female
Humans
Leukemia, Myeloid, Acute genetics
Male
Middle Aged
Mutation
Retrospective Studies
Sulfonamides administration & dosage
Treatment Outcome
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Leukemia, Myeloid, Acute drug therapy

Full Text Access

Tools